CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. (Q41927071)
Jump to navigation
Jump to search
scientific article published on March 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. |
scientific article published on March 1998 |
Statements
CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation (English)
Céfaï D
Schneider H
Matangkasombut O
Kang H
Brody J